Effect of Acupoint Application Therapy Combined with Interferonα1b Nebulization for Children with Bronchitis and Airway Inflammatory Response
Objective To explore acupoint application therapy combined with interferon αof 1b nebulization on airway inflammatory response of children with bronchitis.Methods The paper chose 100 children with bronchitis in our hospital from May 2022 to May 2023 as study subjects,and divided them into experimental group(n=50)and control group(n=50)with blind method.Reference group was treated with routine treatment,while experimental group with acupoint application therapy combined with interferon α 1b nebulization.Curative effect,adverse reactions,and airway inflammation reactions were compared before and after treatment between two groups.Results Total effective rate of 94.00%in experimental group was significantly higher than 80.00%in reference group(P=0.037).After treatment,CRP levels in both groups decreased,CRP levels in experimental group were lower than control group(both P<0.05).Adverse reaction rate in experimental group was 4.00%,significantly lower than 18.00%in reference group(P=0.025).Conclusion Acupoint application therapy combined with interferon α 1b nebulization can improve curative effect on children with bronchitis,reduce airway inflammation and adverse reactions effectively,which is worthy of clinical reference and application.
NETL
NSTL
万方数据
